Collectively, the investigation of transcriptional changes in genes associated with AD, such as CPNE1, ISG15, LDLR, and GAL3BP, whose expressions are altered in the skin cells of AD patients, may contribute to the development of AD diagnostic tools and methods using the skin. This evidence concerns the gene ISG15 and Alzheimer disease.